Stenocare A/S (CPSE: STENO)
Health Care · Pharmaceuticals · DK
Dkr0.73
-15.63% today · -44.2% 1Y
Stenocare A/S (CPSE: STENO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.66M and employs 4 people.
Over the last twelve months the share price has lost 44.2%, trading between 0.75 and 2.80.
Tweenvest scores Stenocare A/S across four factors: quality 37/100, value 55/100. Its strongest factor is value.
STENO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.66M
- Revenue (TTM)
- $1.76M
- P/E
- —
- EPS
- -0.03
- Dividend yield
- —
- Beta (5Y)
- 0.47
- 52-week high
- Dkr2.80
- 52-week low
- Dkr0.75
- Avg volume (3M)
- —
- Shares outstanding
- 43.20M
- Employees
- 4
- Next earnings
- —
About Stenocare A/S
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD oil products. The company was incorporated in 2017 and is based in Randers, Denmark.
- ISIN
- DK0061078425
- Founded
- 2017
- Listed since
- May 18, 2020
- Exchange
- OMX Nordic Exchange Copenhagen
- Currency
- DKK
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Gelteq LimitedNasdaqCM: GELS | $5.83M | $0.55 | +5.51% |
| Invex Therapeutics LtdASX: IXC | $5.81M | AU$0.11 | -4.35% |
| Rekvina Laboratories LimitedBSE: 526075 | $5.76M | Rs49.86 | -0.08% |
| Pulmatrix, Inc.NasdaqCM: PULM | $5.73M | $1.46 | -7.32% |
| Firebrick Pharma LimitedASX: FRE | $5.57M | AU$0.03 | +7.69% |
| Lamdong Pharmaceutical Joint Stock CompanyHNX: LDP | $5.55M | ₫7,700.00 | -1.28% |
| Avant Brands Inc.TSX: AVNT | $5.50M | CA$0.53 | +3.92% |
| ANG Lifesciences India LimitedBSE: 540694 | $5.45M | Rs40.18 | -0.22% |
Figures last refreshed Oct 4, 2026.